Christine L. Lau, MD
Dr. Christine Lau is a thoracic surgeon and the Chief of Surgery at the University of Maryland School of Medicine in Baltimore, Maryland, as well as the chief of surgery at the University of Maryland Medical Center.[1] She is a nationally renowned thoracic and lung transplant surgeon who has significant experience in treating patients with thoracic illnesses and injuries of all kinds, including malignant mesothelioma and lung cancer.
Education and Career
Dr. Lau earned her medical degree from Dartmouth Medical School. She completed an internship and residency in General Surgery at Duke University Medical Center and then went to Washington University in St Louis to complete fellowships in cardiothoracic surgery and lung transplantation. Dr. Lau also earned an MBA from UVA’s Darden School of Business with a focus on management and leadership development.[1]
After completing her medical education and training, Dr. Lau served as an assistant professor of surgery at the University of Michigan School of Medicine in Ann Arbor, Michigan before accepting her role at the University of Virginia, where she helped build the lung transplant program to be among the best in the nation for patient outcomes and was named the George Minor Professor of Surgery and Chief of the Division of Thoracic Surgery.[1]
Professional Activities and Memberships
Dr. Lau serves as director of the American Board of Thoracic Surgery and serves on the Board for the American Association for Thoracic Surgeons. She is also on the expert panel for Leap Frog, which collects and reports on hospital performance, and on the National Heart, Lung, and Blood Institute Study Section for Anesthesiology and Trauma Research.[1]
She is also a member of:[1]
- American Association of Thoracic Surgeons
- American College of Surgeons
- Society of Thoracic Surgeons
- Women in Thoracic Surgery
- International Society of Heart & Lung Transplantation
- Southern Thoracic Surgical Association
- American Society of Transplant Surgeons
- Alpha Omega Alpha Medical Honor Society
She is a founding member of the Mosenthal Surgical Society; a member of the Sabiston Surgical Society; a member of the John Alexander Surgical Society; and a member of the Muller-Jones Surgical Society.
Research
Dr. Lau’s research focuses on the use of Regadenoson (an adenosine 2A receptor agonist) for use in human lung transplantation and is the recipient of a $3.3 million grant from the National Institutes of Health to investigate its use. She also studies lung cancer screening, lung injury and inflammation, transtracheal oxygen, scoop catheter, photodynamic therapy, endoscopic bronchial ultrasound, endobronchial ultrasound bronchoscopy, and thoracic surgery.[1]
She has authored or co-authored more than 140 articles in leading publications including the Journal of Thoracic & Cardiovascular Surgery, Annals of Thoracic Surgery, and the American Journal of Transplantation. She has also written or contributed chapters to 35 medical textbooks on her specialty interests.[1]
Her highlighted publications include:[1]
JunBeller JP; Hawkins RB; Mehaffey JH; Chancellor WZ; Teaster R; WaltersDM;
Krupnick AS; Davis RD; Lau CL. Poor Performance Flagging is Associated With Fewer
Transplants at Centers Flagged Multiple Times. Ann Thorac Surg 2019 Jan 07.
Martin LW; Sarosiek BM; Harrison MA; Hedrick T; Isbell JM; Krupnick AS; Lau CL;
Mehaffey JH; Thiele RH; Walters DM; Blank RS. Implementing a Thoracic Enhanced
Recovery Program: Lessons Learned in the First Year. Ann Thorac Surg 105(6): 1597-1604,
2018
Charles EJ; Mehaffey JH; Sharma AK; Zhao Y; Stoler MH; Isbell JM; Lau CL;
Tribble CG; Laubach VE; Kron IL. Lungs donated after circulatory death and prolonged warm
ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine
A2B receptor antagonism. JTCVS 154(5): 1811-1820. 2017 Nov.
Stringham JR; Phillips JV; McMurry TL; Lambert DL; Jones DR; Isbell JM; Lau CL;
Kozower BD. Prospective study of giant paraesophageal hernia repair with 1-year follow-up.
JTCVS 154(2):743-751, 2017 Aug.
Raphael J; Collins SR; Wang XQ; Scalzo DC; Singla P; Lau CL; Kozower BD;
Durieux ME; Blank RS. Perioperative statin use is associated with decreased incidence of
primary graft dysfunction after lung transplantation. Journal of Heart & Lung Transplantation.
36(9):948-956, 2017 Sep.
